EVALUATION OF THE EFFECT OF METFORMIN ON SERUM INFLAMMATORY BIOMARKERS (CRP, IL-6) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. RMSR 2025, 3 (5), 982-987.